Literature DB >> 33302594

The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine.

Deyana D Lewis1, Cheryl D Cropp2.   

Abstract

Prostate cancer disproportionately affects men of African ancestry at nearly twice the rate of men of European ancestry despite the advancement of treatment strategies and prevention. In this review, we discuss the underlying causes of these disparities including genetics, environmental/behavioral, and social determinants of health while highlighting the implications and challenges that contribute to the stark underrepresentation of men of African ancestry in clinical trials and genetic research studies. Reducing prostate cancer disparities through the development of personalized medicine approaches based on genetics will require a holistic understanding of the complex interplay of non-genetic factors that disproportionately exacerbate the observed disparity between men of African and European ancestries.

Entities:  

Keywords:  African ancestry; clinical trials; genetics; health disparity; prostate cancer

Year:  2020        PMID: 33302594      PMCID: PMC7762993          DOI: 10.3390/genes11121471

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  265 in total

1.  Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC).

Authors:  Agnes B Baffoe-Bonnie; Rick A Kittles; Elizabeth Gillanders; Liang Ou; Asha George; Christiane Robbins; Chiledum Ahaghotu; James Bennett; William Boykin; Gerald Hoke; Terry Mason; Curtis Pettaway; Srinivasan Vijayakumar; Sally Weinrich; Mary P Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Tracy Moses; Erica Lockwood; Meghan Klaric; Mezbah Faruque; Charmaine Royal; Jeffrey M Trent; Kate Berg; Francis S Collins; Paulette M Furbert-Harris; Joan E Bailey-Wilson; Georgia M Dunston; Isaac Powell; John D Carpten
Journal:  Prostate       Date:  2007-01-01       Impact factor: 4.104

2.  It's a Matter of Trust: Older African Americans Speak About Their Health Care Encounters.

Authors:  Bryan R Hansen; Nancy A Hodgson; Laura N Gitlin
Journal:  J Appl Gerontol       Date:  2015-02-09

3.  Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

Authors:  Rong Na; S Lilly Zheng; Misop Han; Hongjie Yu; Deke Jiang; Sameep Shah; Charles M Ewing; Liti Zhang; Kristian Novakovic; Jacqueline Petkewicz; Kamalakar Gulukota; Donald L Helseth; Margo Quinn; Elizabeth Humphries; Kathleen E Wiley; Sarah D Isaacs; Yishuo Wu; Xu Liu; Ning Zhang; Chi-Hsiung Wang; Janardan Khandekar; Peter J Hulick; Daniel H Shevrin; Kathleen A Cooney; Zhoujun Shen; Alan W Partin; H Ballentine Carter; Michael A Carducci; Mario A Eisenberger; Sam R Denmeade; Michael McGuire; Patrick C Walsh; Brian T Helfand; Charles B Brendler; Qiang Ding; Jianfeng Xu; William B Isaacs
Journal:  Eur Urol       Date:  2016-12-15       Impact factor: 20.096

4.  Neighborhood disorder, psychological distress, and heavy drinking.

Authors:  Terrence D Hill; Ronald J Angel
Journal:  Soc Sci Med       Date:  2005-02-19       Impact factor: 4.634

5.  Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.

Authors:  Farzana A Faisal; Debasish Sundi; Jeffrey J Tosoian; Voleak Choeurng; Mohammed Alshalalfa; Ashley E Ross; Eric Klein; Robert Den; Adam Dicker; Nicholas Erho; Elai Davicioni; Tamara L Lotan; Edward M Schaeffer
Journal:  Eur Urol       Date:  2015-10-09       Impact factor: 20.096

6.  Relationship between dietary factors and prostate-specific antigen in healthy men.

Authors:  Kazuhiro Ohwaki; Fumiyasu Endo; Yuko Kachi; Kazunori Hattori; Osamu Muraishi; Mariko Nishikitani; Eiji Yano
Journal:  Urol Int       Date:  2012-07-10       Impact factor: 2.089

7.  Topic choice contributes to the lower rate of NIH awards to African-American/black scientists.

Authors:  Travis A Hoppe; Aviva Litovitz; Kristine A Willis; Rebecca A Meseroll; Matthew J Perkins; B Ian Hutchins; Alison F Davis; Michael S Lauer; Hannah A Valantine; James M Anderson; George M Santangelo
Journal:  Sci Adv       Date:  2019-10-09       Impact factor: 14.136

8.  TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa.

Authors:  James Blackburn; Stefano Vecchiarelli; Erin E Heyer; Sean M Patrick; Ruth J Lyons; Weerachai Jaratlerdsiri; Smit van Zyl; M S Riana Bornman; Tim R Mercer; Vanessa M Hayes
Journal:  Prostate       Date:  2019-05-15       Impact factor: 4.104

9.  Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.

Authors:  Elena Castro; Chee Goh; David Olmos; Ed Saunders; Daniel Leongamornlert; Malgorzata Tymrakiewicz; Nadiya Mahmud; Tokhir Dadaev; Koveela Govindasami; Michelle Guy; Emma Sawyer; Rosemary Wilkinson; Audrey Ardern-Jones; Steve Ellis; Debra Frost; Susan Peock; D Gareth Evans; Marc Tischkowitz; Trevor Cole; Rosemarie Davidson; Diana Eccles; Carole Brewer; Fiona Douglas; Mary E Porteous; Alan Donaldson; Huw Dorkins; Louise Izatt; Jackie Cook; Shirley Hodgson; M John Kennedy; Lucy E Side; Jacqueline Eason; Alex Murray; Antonis C Antoniou; Douglas F Easton; Zsofia Kote-Jarai; Rosalind Eeles
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544

10.  A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.

Authors:  Gyorgy Petrovics; Hua Li; Tanja Stümpel; Shyh-Han Tan; Denise Young; Shilpa Katta; Qiyuan Li; Kai Ying; Bernward Klocke; Lakshmi Ravindranath; Indu Kohaar; Yongmei Chen; Dezső Ribli; Korbinian Grote; Hua Zou; Joseph Cheng; Clifton L Dalgard; Shimin Zhang; István Csabai; Jacob Kagan; David Takeda; Massimo Loda; Sudhir Srivastava; Matthias Scherf; Martin Seifert; Timo Gaiser; David G McLeod; Zoltan Szallasi; Reinhard Ebner; Thomas Werner; Isabell A Sesterhenn; Matthew Freedman; Albert Dobi; Shiv Srivastava
Journal:  EBioMedicine       Date:  2015-10-31       Impact factor: 8.143

View more
  3 in total

1.  Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men.

Authors:  Paul Katongole; Obondo J Sande; Steven J Reynolds; Moses Joloba; Henry Kajumbula; Samuel Kalungi; Kenneth Ssebambulidde; Cynthia Nakimuli; Maxine Atuheirwe; Jackson Orem; Nixon Niyonzima
Journal:  Oncol Ther       Date:  2022-02-07

Review 2.  Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.

Authors:  Rahaba Marima; Rodney Hull; Mandisa Mbeje; Thulo Molefi; Kgomotso Mathabe; Abdulrahman M Elbagory; Demetra Demetriou; Zodwa Dlamini
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

3.  Haplotypes of single cancer driver genes and their local ancestry in a highly admixed long-lived population of Northeast Brazil.

Authors:  Steffany Larissa Galdino Galisa; Priscila Lima Jacob; Allysson Allan de Farias; Renan Barbosa Lemes; Leandro Ucela Alves; Júlia Cristina Leite Nóbrega; Mayana Zatz; Silvana Santos; Mathias Weller
Journal:  Genet Mol Biol       Date:  2022-02-02       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.